Forsteo 250 μg/mL

Forsteo 250 μg/mL is a medicine authorised by Swissmedic under authorisation number 56007. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 August 2003 and the authorisation is valid without a time limit. ATC code H05AA02 places the medicine in the group Calcium homeostasis.

  • Dispensing category B
  • Authorisation number 56007
  • ATC H05AA02
  • Biotechnological medicines
Authorisation data
Authorisation number56007
NameForsteo 250 μg/mL
Full nameForsteo 250 μg/mL, solution injectable en stylo prérempli
Authorisation holderEli Lilly (Suisse) SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeH05AA02
First authorisation08 August 2003
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Forsteo 250 μg/mL, solution injectable en stylo prérempliB08 August 2003

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
21StückH05AA0207.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Forsteo 250 μg/mL authorised in Switzerland?

Yes. Forsteo 250 μg/mL is authorised by Swissmedic under authorisation number 56007, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Forsteo 250 μg/mL have?

Forsteo 250 μg/mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Forsteo 250 μg/mL?

The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com